Un Audited Financial results for the quarter ended 30.06.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeevan Scientific Technology Limited reported weak Q1 FY26 results, swinging from a profit to a loss on both standalone and consolidated bases. Standalone revenue from operations fell to ₹821.57 lakhs, down about 34% from ₹1,251.66 lakhs in the same quarter last year. The company posted a standalone loss after tax of ₹215.99 lakhs versus a profit of ₹160.08 lakhs in Q1 FY25, with EPS at negative ₹1.36. On a consolidated basis, revenue dropped to ₹879.91 lakhs (from ₹1,288.03 lakhs), and the loss after tax widened to ₹321.91 lakhs compared to a profit of ₹102.62 lakhs a year ago. Total expenses exceeded total income on both bases, driven by higher employee costs and other expenses even as finance costs more than doubled. The statutory auditor issued an unmodified limited review conclusion with no qualifications or emphasis of matter. The subsidiary Nayas Laboratories contributed a net loss of about ₹105.92 lakhs on revenues of ₹61.35 lakhs for the quarter.
Shareholders should note that the company has slipped into losses with sharp revenue contraction and rising costs, which is a negative signal for near-term earnings. The unmodified auditor opinion provides some comfort on reporting quality, but the deteriorating operating performance is likely to weigh on investor sentiment and the stock in the short term.